Summary
Boston Scientific Corporation (BSX) has filed an 8-K report detailing updates to its executive compensation structure for 2023. The Board of Directors has approved the 2023 Annual Bonus Plan and two new performance share programs: the 2023 Relative Total Shareholder Return Performance Share Program (rTSR PSP) and the 2023 Organic Net Sales Growth Performance Share Program (Organic Net Sales PSP). These plans are designed to incentivize executive performance based on key financial and operational metrics, aligning management's interests with those of shareholders. The 2023 Annual Bonus Plan will be based on corporate-level performance goals including adjusted earnings per share, global sales (at constant currency, excluding M&A impacts), ESG Scorecard metrics, and a quality assessment. The performance share programs are long-term incentives, with the rTSR PSP measuring the Company's total shareholder return against the S&P 500 Healthcare Index over three years, and the Organic Net Sales PSP focusing on three-year organic net sales growth against the Company's financial plan. Both programs and the annual bonus plan include provisions for clawbacks and recoupment in cases of executive misconduct, gross dereliction of duty, or financial restatements that would have impacted bonus amounts.
Key Highlights
- 1Approval of the 2023 Annual Bonus Plan, with performance tied to adjusted EPS, global sales, ESG, and quality metrics.
- 2Introduction of the 2023 Relative Total Shareholder Return Performance Share Program (rTSR PSP) to align executive pay with shareholder returns relative to the S&P 500 Healthcare Index.
- 3Implementation of the 2023 Organic Net Sales Growth Performance Share Program (Organic Net Sales PSP) to incentivize growth in net sales, excluding currency and M&A impacts.
- 4Both performance share programs are three-year programs, commencing January 1, 2023, and ending December 31, 2025.
- 5Executive compensation awards under these plans are subject to recoupment policies in cases of executive misconduct, material policy violations, significant harm to the company, or financial restatements.
- 6The 2023 rTSR PSP can award between 0% to 200% of target awards based on relative TSR rank.
- 7The 2023 Organic Net Sales PSP can award between 0% to 200% of target awards based on organic net sales growth performance.